I would like to share with you an excerpt of an article I wrote for the forthcoming quarterly newsletter from Pharmig. It is about an open discussion session I participated in back at the Pharmig Annual Conference back in November called “Culture Media – Back to Basics”. Chaired by Dr Tim Sandle from BPL, it was an attempt to get some consensus on how microbiological media is handled and used in the pharmaceutical industry. The findings from a few of the questions asked are below:
When monitoring areas at rest it is important that the operator setting the samples doesn’t influence the sample result. Placing settle plates and/or setting up active air samplers presents a contamination risk. This could lead to false positives which create a lot of unnecessary investigative work, which is both time consuming and costly.
Despite being a small company, an increasing proportion of our business is in mainland Europe through our Redipor distributors. For many years we have been selling Redipor media to Italy thanks to our relationship with what was PBI (now part of VWR). In recent years we have begun to supply media via distributors in Poland, Slovenia and Denmark amongst others.
I’ve recently found myself recently doing some data analysis from searches on our website along with my other jobs. I must admit to being a bit of a nerd (of course you are I hear you say, you’re a scientist!). So looking at facts and a figures and trying to interpret them is right up my street. On this occasion the facts and figures I was asked to analyse were failed search results, where no links were suggested for a particular search. I...